Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
18.47
-0.39 (-2.07%)
BSENSE

Nov 20

BSE+NSE Vol: 2.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002925,
    "name": "Medico Remedies",
    "stock_name": "Medico Remedies",
    "full_name": "Medico Remedies Ltd",
    "name_url": "stocks-analysis/medico-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.47",
    "chg": -0.39,
    "chgp": "-2.07%",
    "dir": -1,
    "prev_price": "18.86",
    "mcapval": "155.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540937,
    "symbol": "MEDICO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE630Y01024",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.77 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medico Remedies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-4267842",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MedicoRemediesL_mojoScore_4267842.png",
        "date": "2026-11-19 10:10:57",
        "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Medico Remedies Ltd Falls to 52-Week Low of Rs 18.22 Amidst Prolonged Downtrend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/medico-remedies-ltd-falls-to-52-week-low-of-rs1822-amidst-continued-underperformance-4254199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MedicoRemediesL_priceRelatedfactors_4254199.png",
        "date": "2026-11-06 11:14:02",
        "description": "A sustained decline has pushed Medico Remedies Ltd to a fresh 52-week low of Rs 18.22 on 6 Nov 2026, marking a 63.17% drop over the past year despite the broader market showing resilience."
      },
      {
        "title": "Medico Remedies Ltd Falls to 52-Week Low of Rs 19 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/medico-remedies-ltd-falls-to-52-week-low-of-rs-19-amid-continued-underperformance-4242275",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MedicoRemediesL_priceRelatedfactors_4242275.png",
        "date": "2026-10-28 11:37:29",
        "description": "For the fifth consecutive session, Medico Remedies Ltd closed lower, breaching its 52-week low at Rs 19 on 28 Oct 2026, marking a 6.4% decline intraday despite opening with a modest gain. This persistent downward pressure has dragged the stock down by over 61% in the past year, significantly underperforming the broader Sensex, which itself is nearing its own 52-week low."
      },
      {
        "title": "Medico Remedies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-4240551",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MedicoRemediesL_mojoScore_4240551.png",
        "date": "2026-10-27 10:11:20",
        "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 October 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Medico Remedies Ltd Falls to 52-Week Low of Rs 20.5 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/medico-remedies-ltd-stock-hits-52-week-low-amid-continued-downtrend-4234102",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MedicoRemediesL_priceRelatedfactors_4234102.png",
        "date": "2026-10-22 12:38:57",
        "description": "For the sixth consecutive session, Medico Remedies Ltd has closed lower, culminating in a fresh 52-week low of Rs 20.5 on 22 Oct 2026. This marks a 9.21% decline over the past six days, underscoring sustained selling pressure despite some positive financial indicators."
      },
      {
        "title": "Medico Remedies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-4227611",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MedicoRemediesL_mojoScore_4227611.png",
        "date": "2026-10-16 10:11:10",
        "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 16 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Medico Remedies Gains 4.12%: Valuation Shift and 52-Week Low Mark Key Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/medico-remedies-gains-412-valuation-shift-and-52-week-low-mark-key-week-4221088",
        "imagepath": "",
        "date": "2026-10-10 13:00:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>05 Oct:</strong> Valuation upgrade signals renewed price attractiveness</p>\n                    <p><strong>09 Oct:</strong> Stock falls to 52-week low of Rs.20.52 amid continued downtrend</p>\n                    <p><strong>09 Oct:</strong> Week closes at Rs.22.73 (+4.12%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.21.83</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.22.73</div><div class=\"stat-change positive\">+4.12%</div></div>\n                    <div c..."
      },
      {
        "title": "Medico Remedies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-4214442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MedicoRemediesL_mojoScore_4214442.png",
        "date": "2026-10-05 10:10:51",
        "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 October 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4213841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MedicoRemediesL_valuationdot_4213841.png",
        "date": "2026-10-05 08:04:16",
        "description": "Medico Remedies Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing sector headwinds and a challenging price performance relative to the broader market. This repositioning reflects a notable improvement in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical player as a compelling value proposition within its peer group."
      }
    ],
    "total": 49,
    "sid": "1002925",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/medico-remedies-1002925"
  },
  "announcements": [
    {
      "caption": "Financial Results For Quarter Ended 30Th September 2026.",
      "datetime": "09-Nov-2026",
      "details": "Unaudited Standalone Financial Results for Quarter ended 30th September 2026 along with Auditors limited review report.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Intimation Under Regulation 30 (Read With Part A Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations)",
      "datetime": "09-Nov-2026",
      "details": "1.Unaudited Standalone Financial Results for the quarter ended 30th September 2026 alongwith Auditors",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Quarterly Financial Results",
      "datetime": "03-Nov-2026",
      "details": "Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2026 inter alia to consider and approve To consider and approve Unaudited Financial Results for the quarter ended 30th September2026 along with the Limited Review Report thereon.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23",
          "dt": "2023-03-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21",
          "dt": "2021-11-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Financial Results For Quarter Ended 30Th September 2026.

09-Nov-2026 | Source : BSE

Unaudited Standalone Financial Results for Quarter ended 30th September 2026 along with Auditors limited review report.

Board Meeting Outcome for Intimation Under Regulation 30 (Read With Part A Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations)

09-Nov-2026 | Source : BSE

1.Unaudited Standalone Financial Results for the quarter ended 30th September 2026 alongwith Auditors

Board Meeting Intimation for Quarterly Financial Results

03-Nov-2026 | Source : BSE

Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2026 inter alia to consider and approve To consider and approve Unaudited Financial Results for the quarter ended 30th September2026 along with the Limited Review Report thereon.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Medico Remedies Ltd has announced 2:10 stock split, ex-date: 16 Mar 23

stock-summary
BONUS

Medico Remedies Ltd has announced 3:1 bonus issue, ex-date: 16 Nov 21

stock-summary
RIGHTS

No Rights history available